<p>A Chinese-made <strong><a href="https://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates.html">coronavirus</a></strong> vaccine could be ready for market as early as the end of this year, China's State-owned Assets Supervision and Administration Commission (SASAC) said in a social media post.</p>.<p><strong><a href="https://www.deccanherald.com/national/coronavirus-in-india-news-live-updates-total-cases-deaths-covid-19-tracker-today-worldometer-update-lockdown-40-latest-news-838583.html">Track live updates on coronavirus here</a></strong></p>.<p>In trials, more than 2,000 people have received vaccines developed by the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products. A vaccine could be ready for the market as early as the end of this year or early 2021, according to the May 29 post on Chinese social media platform WeChat.</p>.<p><strong>Also Read: <a href="https://www.deccanherald.com/national/coronavirus-india-update-state-wise-total-number-of-confirmed-cases-deaths-on-may-30-843480.html">Coronavirus India update: State-wise total number of confirmed cases</a></strong></p>.<p>Vaccines from the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products had entered Phase II clinical trials. Both groups are affiliated with state-owned pharmaceutical group Sinopharm, whose management is overseen by SASAC.</p>.<p><strong><a href="https://www.deccanherald.com/international/coronavirus-updates-cases-deaths-country-wise-worldometers-info-data-covid-19-834531.html#1">COVID-19 Pandemic Tracker: 15 countries with the highest number of coronavirus cases, deaths</a></strong></p>.<p>The Beijing Institute of Biological Products' production line will have an annual manufacturing capacity of 100 million to 120 million doses, according to the article.</p>.<p>China has five coronavirus vaccines in human trials. Neither company could be reached for comment on Saturday evening. </p>
<p>A Chinese-made <strong><a href="https://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates.html">coronavirus</a></strong> vaccine could be ready for market as early as the end of this year, China's State-owned Assets Supervision and Administration Commission (SASAC) said in a social media post.</p>.<p><strong><a href="https://www.deccanherald.com/national/coronavirus-in-india-news-live-updates-total-cases-deaths-covid-19-tracker-today-worldometer-update-lockdown-40-latest-news-838583.html">Track live updates on coronavirus here</a></strong></p>.<p>In trials, more than 2,000 people have received vaccines developed by the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products. A vaccine could be ready for the market as early as the end of this year or early 2021, according to the May 29 post on Chinese social media platform WeChat.</p>.<p><strong>Also Read: <a href="https://www.deccanherald.com/national/coronavirus-india-update-state-wise-total-number-of-confirmed-cases-deaths-on-may-30-843480.html">Coronavirus India update: State-wise total number of confirmed cases</a></strong></p>.<p>Vaccines from the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products had entered Phase II clinical trials. Both groups are affiliated with state-owned pharmaceutical group Sinopharm, whose management is overseen by SASAC.</p>.<p><strong><a href="https://www.deccanherald.com/international/coronavirus-updates-cases-deaths-country-wise-worldometers-info-data-covid-19-834531.html#1">COVID-19 Pandemic Tracker: 15 countries with the highest number of coronavirus cases, deaths</a></strong></p>.<p>The Beijing Institute of Biological Products' production line will have an annual manufacturing capacity of 100 million to 120 million doses, according to the article.</p>.<p>China has five coronavirus vaccines in human trials. Neither company could be reached for comment on Saturday evening. </p>